New enzyme combo aims to shrink hard-to-treat pancreatic tumors
Disease control
Ongoing
This study tests whether adding an experimental drug called PEGPH20 to standard chemotherapy (gemcitabine and nab-paclitaxel) and a blood thinner (rivaroxaban) can help shrink advanced pancreatic cancer. PEGPH20 breaks down a substance called hyaluronan, which is often found in l…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC